Redcare Pharmacy NV (SHPPF)
Redcare Pharmacy NV Statistics
Share Statistics
Redcare Pharmacy NV has 20.34M shares outstanding. The number of shares has increased by 1.18% in one year.
| Shares Outstanding | 20.34M |
| Shares Change (YoY) | 1.18% |
| Shares Change (QoQ) | 1.18% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 14.79M |
| Failed to Deliver (FTD) Shares | - |
| FTD / Avg. Volume | < 0.01% |
Short Selling Information
| Short Interest | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Valuation Ratios
The PE ratio is -59.47 and the forward PE ratio is null. Redcare Pharmacy NV's PEG ratio is -0.23.
| PE Ratio | -59.47 |
| Forward PE | n/a |
| PS Ratio | 1.14 |
| Forward PS | n/a |
| PB Ratio | 5.59 |
| P/FCF Ratio | -135.01 |
| PEG Ratio | -0.23 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Redcare Pharmacy NV.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2, with a Debt / Equity ratio of 0.51.
| Current Ratio | 2 |
| Quick Ratio | 1.39 |
| Debt / Equity | 0.51 |
| Debt / EBITDA | 8.79 |
| Debt / FCF | -12.35 |
| Interest Coverage | -5.01 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $1.3M |
| Profits Per Employee | $-24.88K |
| Employee Count | 1,827 |
| Asset Turnover | 2.36 |
| Inventory Turnover | 11.86 |
Taxes
| Income Tax | -1.48M |
| Effective Tax Rate | 3.09% |
Stock Price Statistics
The stock price has increased by -8.25% in the last 52 weeks. The beta is 1.26, so Redcare Pharmacy NV's price volatility has been higher than the market average.
| Beta | 1.26 |
| 52-Week Price Change | -8.25% |
| 50-Day Moving Average | 134.5 |
| 200-Day Moving Average | 137.6 |
| Relative Strength Index (RSI) | 45.2 |
| Average Volume (20 Days) | 6 |
Income Statement
In the last 12 months, Redcare Pharmacy NV had revenue of 2.37B and earned -45.46M in profits. Earnings per share was -2.26.
| Revenue | 2.37B |
| Gross Profit | 545.78M |
| Operating Income | -38.99M |
| Net Income | -45.46M |
| EBITDA | 28.16M |
| EBIT | -40.06M |
| Earnings Per Share (EPS) | -2.26 |
Balance Sheet
The company has 96.61M in cash and 247.38M in debt, giving a net cash position of -150.77M.
| Cash & Cash Equivalents | 96.61M |
| Total Debt | 247.38M |
| Net Cash | -150.77M |
| Retained Earnings | -324.29M |
| Total Assets | 1B |
| Working Capital | 250.29M |
Cash Flow
In the last 12 months, operating cash flow was 22.13M and capital expenditures -42.15M, giving a free cash flow of -20.02M.
| Operating Cash Flow | 22.13M |
| Capital Expenditures | -42.15M |
| Free Cash Flow | -20.02M |
| FCF Per Share | -1 |
Margins
Gross margin is 23.02%, with operating and profit margins of -1.64% and -1.92%.
| Gross Margin | 23.02% |
| Operating Margin | -1.64% |
| Pretax Margin | -2.02% |
| Profit Margin | -1.92% |
| EBITDA Margin | 1.19% |
| EBIT Margin | -1.64% |
| FCF Margin | -0.84% |
Dividends & Yields
SHPPF does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
Currently there are no analyst rating for SHPPF.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Scores
| Altman Z-Score | 5.44 |
| Piotroski F-Score | 4 |